Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease
Clinical trial NCT00749216 · COMPLETED
Trial details
- NCT number
- NCT00749216
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.